Navigate to
-
Zabrina Watkins Our passion Our people “At Prime we’re committed to creating an open, inclusive culture that’s purpose-oriented and focused on providing meaningful work for our employees. To do...
-
Oncology Insights On May 16, the U.S. Food and Drug Administration (FDA) granted accelerated approval to intravenous Imdelltra™ (tarlatamab) for the treatment of adults with relapsed/refractory...
-
Traditional Feb. 28, 2025 – denosumab-bmwo (Osenvelt) BLA approval; denosumab-bmwo (Osenvelt) is a biosimilar to reference drug denosumab (Xgeva) RANK ligand inhibitor Osenvelt is indicated for (1)...
-
Tennessee pharmacies In accordance with Texas Senate Bill 1236, Prime Therapeutics provides Texas-based pharmacies with secure online access to their pharmacy benefit network contracts that were...